123 related articles for article (PubMed ID: 1733935)
1. Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.
Engler DA; Campion SR; Hauser MR; Cook JS; Niyogi SK
J Biol Chem; 1992 Feb; 267(4):2274-81. PubMed ID: 1733935
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification.
Campion SR; Tadaki DK; Niyogi SK
J Cell Biochem; 1992 Sep; 50(1):35-42. PubMed ID: 1358899
[TBL] [Abstract][Full Text] [Related]
3. The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
Tadaki DK; Niyogi SK
J Biol Chem; 1993 May; 268(14):10114-9. PubMed ID: 8486681
[TBL] [Abstract][Full Text] [Related]
4. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
Campion SR; Matsunami RK; Engler DA; Niyogi SK
Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
[TBL] [Abstract][Full Text] [Related]
5. The role of asparagine-32 in forming the receptor-binding epitope of human epidermal growth factor.
Campion SR; Biamonti C; Montelione GT; Niyogi SK
Protein Eng; 1993 Aug; 6(6):651-9. PubMed ID: 8234236
[TBL] [Abstract][Full Text] [Related]
6. The functional importance of Leu15 of human epidermal growth factor in receptor binding and activation.
Nandagopal K; Tadaki DK; Lamerdin JA; Serpersu EH; Niyogi SK
Protein Eng; 1996 Sep; 9(9):781-8. PubMed ID: 8888144
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor.
van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ
J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217
[TBL] [Abstract][Full Text] [Related]
8. Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.
Engler DA; Montelione GT; Niyogi SK
FEBS Lett; 1990 Oct; 271(1-2):47-50. PubMed ID: 2172006
[TBL] [Abstract][Full Text] [Related]
9. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
[TBL] [Abstract][Full Text] [Related]
10. Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.
Engler DA; Hauser MR; Cook JS; Niyogi SK
Mol Cell Biol; 1991 May; 11(5):2425-31. PubMed ID: 1850095
[TBL] [Abstract][Full Text] [Related]
11. Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32.
Koide H; Muto Y; Kasai H; Hoshi K; Takusari H; Kohri K; Takahashi S; Sasaki T; Tsukumo K; Miyake T
FEBS Lett; 1992 May; 302(1):39-42. PubMed ID: 1587350
[TBL] [Abstract][Full Text] [Related]
12. Receptor-binding affinities of human epidermal growth factor variants having unnatural amino acid residues in position 23.
Koide H; Yokoyama S; Katayama Y; Muto Y; Kigawa T; Kohno T; Takusari H; Oishi M; Takahashi S; Tsukumo K
Biochemistry; 1994 Jun; 33(23):7470-6. PubMed ID: 8003512
[TBL] [Abstract][Full Text] [Related]
13. Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.
Campion SR; Geck MK; Niyogi SK
J Biol Chem; 1993 Jan; 268(3):1742-8. PubMed ID: 8380576
[TBL] [Abstract][Full Text] [Related]
14. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
Nandagopal K; Popp DM; Niyogi SK
J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
[TBL] [Abstract][Full Text] [Related]
15. L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.
Khangulov SV; Sossong TM; Ash DE; Dismukes GC
Biochemistry; 1998 Jun; 37(23):8539-50. PubMed ID: 9622506
[TBL] [Abstract][Full Text] [Related]
16. Receptor recognition by histidine 16 of human epidermal growth factor via hydrogen-bond donor/acceptor interactions.
Nandagopal K; Terzaghi-Howe M; Niyogi SK
J Cell Biochem; 1999 Jan; 72(1):16-24. PubMed ID: 10025663
[TBL] [Abstract][Full Text] [Related]
17. Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity.
van de Poll ML; van Vugt MJ; Lenferink AE; van Zoelen EJ
Biochemistry; 1997 Jun; 36(24):7425-31. PubMed ID: 9200690
[TBL] [Abstract][Full Text] [Related]
18. pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes.
Maeda K; Kato Y; Sugiyama Y
J Control Release; 2002 Jul; 82(1):71-82. PubMed ID: 12106978
[TBL] [Abstract][Full Text] [Related]
19. A site-directed mutagenesis study on the role of isoleucine-23 of human epidermal growth factor in the receptor binding.
Koide H; Muto Y; Kasai H; Kohri K; Hoshi K; Takahashi S; Tsukumo K; Sasaki T; Oka T; Miyake T
Biochim Biophys Acta; 1992 Apr; 1120(3):257-61. PubMed ID: 1576151
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of a conserved aromatic cluster in the N-terminal domain of human epidermal growth factor.
Murray MB; Tadaki DK; Campion SR; Lamerdin JA; Serpersu EH; Bradrick TD; Niyogi SK
Protein Eng; 1998 Nov; 11(11):1041-50. PubMed ID: 9876925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
